227
Views
2
CrossRef citations to date
0
Altmetric
Review

Racial and ethnic differences in cardiovascular disease and outcome in type 1 diabetes patients

&
Pages 225-231 | Received 21 Dec 2018, Accepted 29 Apr 2019, Published online: 13 May 2019

References

  • Maahs DM, Rewers M. Editorial: mortality and renal disease in type 1 diabetes mellitus–progress made, more to be done. J Clin Endocrinol Metab. 2006 Oct;91(10):3757–3759.
  • Writing Team for the Diabetes C, Complications Trial/Epidemiology of Diabetes I, Complications Research G. . Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. JAMA. 2003 Oct 22;290(16):2159–2167.
  • Bluestone JA, Herold K, Eisenbarth G. Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature. 2010 Apr 29;464(7293):1293–1300.
  • Harjutsalo V, Sjoberg L, Tuomilehto J. Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study. Lancet. 2008 May 24;371(9626):1777–1782.
  • Lorenzen T, Pociot F, Hougaard P, et al. Long-term risk of IDDM in first-degree relatives of patients with IDDM. Diabetologia. 1994 Mar;37(3):321–327.
  • American Diabetes A. Diagnosis and classification of diabetes mellitus.Diabetes Care. 2009 Jan;32(Suppl 1):S62–7.
  • Group SfDiYS, Ad L, D‘Agostino RB Jr., et al. The burden of diabetes mellitus among US youth: prevalence estimates from the SEARCH for diabetes in youth study. Pediatrics. 2006 Oct;118(4):1510–1518.
  • Writing Group for the SfDiYSG. Dabelea D, Ra B, et al. Incidence of diabetes in youth in the United States. JAMA. 2007 Jun 27;297(24):2716–2724.
  • Maahs DM, West NA, Lawrence JM, et al. Epidemiology of type 1 diabetes. Endocrinol Metab Clin North Am. 2010 Sep;39(3):481–497.
  • Centers for Disease Control and Prevention. National Diabetes Statistics Report A, GA: Centers for Disease Control and Prevention, U.S. Dept of Health and Human Services; 2017.
  • Emerging Risk Factors C, Sarwar N, Gao P, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010 Jun 26;375(9733):2215–2222.
  • Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004 May;27(5):1047–1053.
  • Gale EA. The rise of childhood type 1 diabetes in the 20th century. Diabetes. 2002 Dec;51(12):3353–3361.
  • Mac Donald MJ. Lower frequency of diabetes among hospitalized Negro than white children: theoretical implications. Acta Genet Med Gemellol. 1975;24(1–2):119–126.
  • Karvonen M, Viik-Kajander M, Moltchanova E, et al. Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) project group. Diabetes Care. 2000 Oct;23(10):1516–1526.
  • Lorenzi M, Cagliero E, Schmidt NJ. Racial differences in incidence of juvenile-onset type 1 diabetes: epidemiologic studies in southern California. Diabetologia. 1985 Oct;28(10):734–738.
  • Christau B, Kromann H, Andersen OO, et al. Incidence, seasonal and geographical patterns of juvenile-onset insulin-dependent diabetes mellitus in Denmark. Diabetologia. 1977 Aug;13(4):281–284.
  • Sterky G, Holmgren G, Gustavson KH, et al. The incidence of diabetes mellitus in Swedish children 1970–1975. Acta Paediatrica Scand. 1978 Mar;67(2):139–143.
  • Joner G, Sovik O. Incidence, age at onset and seasonal variation of diabetes mellitus in Norwegian children, 1973–1977. Acta Paediatrica Scand. 1981;70(3):329–335.
  • Patterson CC, Thorogood M, Smith PG, et al. Epidemiology of type 1 (insulin-dependent) diabetes in Scotland 1968–1976: evidence of an increasing incidence. Diabetologia. 1983 Apr;24(4):238–243.
  • Shamis I, Gordon O, Albag Y, et al. Ethnic differences in the incidence of childhood IDDM in Israel (1965–1993). Marked increase since 1985, especially in Yemenite Jews. Diabetes Care. 1997 Apr;20(4):504–508.
  • Onkamo P, Vaananen S, Karvonen M, et al. Worldwide increase in incidence of Type I diabetes–the analysis of the data on published incidence trends. Diabetologia. 1999 Dec;42(12):1395–1403.
  • Gamble DR. The epidemiology of insulin dependent diabetes with particular reference to the relationship of virus infection to its etiology. Epidemiol Rev. 1980;2:49–70.
  • Colle E, Siemiatycki J, West R, et al. Incidence of juvenile onset diabetes in Montreal-demonstration of ethnic differences and socio-economic class differences. J Chron Dis. 1981;34(12):611–616.
  • Fleegler FM, Rogers KD, Drash A, et al. Age, sex, and season of onset of juvenile diabetes in different geographic areas. Pediatrics. 1979 Mar;63(3):374–379.
  • Bell RA, Mayer-Davis EJ, Beyer JW, et al. Diabetes in non-Hispanic white youth: prevalence, incidence, and clinical characteristics: the SEARCH for Diabetes in Youth Study. Diabetes Care. 2009 Mar;32(Suppl 2):S102–11.
  • Mayer-Davis EJ, Beyer J, Bell RA, et al. Diabetes in African American youth: prevalence, incidence, and clinical characteristics: the SEARCH for Diabetes in Youth Study. Diabetes Care. 2009 Mar;32(Suppl 2):S112–22.
  • Lawrence JM, Mayer-Davis EJ, Reynolds K, et al. Diabetes in Hispanic American youth: prevalence, incidence, demographics, and clinical characteristics: the search for Diabetes in youth study. Diabetes Care. 2009 Mar;32(Suppl 2):S123–32.
  • Liu LL, Yi JP, Beyer J, et al. Type 1 and Type 2 diabetes in Asian and Pacific Islander U.S. youth: the SEARCH for diabetes in youth study. Diabetes Care. 2009 Mar;32(Suppl 2):S133–40.
  • Dabelea D, DeGroat J, Sorrelman C, et al. Diabetes in Navajo youth: prevalence, incidence, and clinical characteristics: the SEARCH for diabetes in youth study. Diabetes Care. 2009 Mar;32(Suppl 2):S141–7.
  • Redondo MJ, Fain PR, Eisenbarth GS. Genetics of type 1A diabetes. Recent Prog Horm Res. 2001;56:69–89.
  • Redondo MJ, Jeffrey J, Fain PR, et al. Concordance for islet autoimmunity among monozygotic twins. N Engl J Med. 2008 Dec 25;359(26):2849–2850.
  • Gillespie KM, Gale EA, Bingley PJ. High familial risk and genetic susceptibility in early onset childhood diabetes. Diabetes. 2002 Jan;51(1):210–214.
  • Hamalainen AM, Knip M. Autoimmunity and familial risk of type 1 diabetes. Curr Diab Rep. 2002 Aug;2(4):347–353.
  • Alhonen S, Korhonen S, Tapanainen P, et al. Extended family history of diabetes and autoimmune diseases in children with and without type 1 diabetes. Diabetes Care. 2011 Jan;34(1):115–117.
  • Mehers KL, Gillespie KM. The genetic basis for type 1 diabetes. Br Med Bull. 2008;88(1):115–129.
  • Platz P, Jakobsen BK, Morling N, et al. HLA-D and -DR antigens in genetic analysis of insulin dependent diabetes mellitus. Diabetologia. 1981 Aug;21(2):108–115.
  • LaPorte RE, Orchard TJ, Kuller LH, et al. The Pittsburgh insulin dependent diabetes mellitus registry: the relationship of insulin dependent diabetes mellitus incidence to social class. Am J Epidemiol. 1981 Sep;114(3):379–384.
  • Ounissi-Benkalha H, Polychronakos C. The molecular genetics of type 1 diabetes: new genes and emerging mechanisms. Trends Mol Med. 2008 Jun;14(6):268–275.
  • Concannon P, Erlich HA, Julier C, et al. Type 1 diabetes: evidence for susceptibility loci from four genome-wide linkage scans in 1,435 multiplex families. Diabetes. 2005 Oct;54(10):2995–3001.
  • Lambert AP, Gillespie KM, Thomson G, et al. Absolute risk of childhood-onset type 1 diabetes defined by human leukocyte antigen class II genotype: a population-based study in the United Kingdom. J Clin Endocrinol Metab. 2004 Aug;89(8):4037–4043.
  • Virtanen SM, Knip M. Nutritional risk predictors of beta cell autoimmunity and type 1 diabetes at a young age. Am J Clin Nutr. 2003 Dec;78(6):1053–1067.
  • Edghill EL, Dix RJ, Flanagan SE, et al. HLA genotyping supports a nonautoimmune etiology in patients diagnosed with diabetes under the age of 6 months. Diabetes. 2006 Jun;55(6):1895–1898.
  • Lloyd-Jones D, Adams R, Carnethon M, et al. Heart disease and stroke statistics–2009 update: a report from the American heart association statistics committee and stroke statistics subcommittee. Circulation. 2009 Jan 27;119(3):e21–181.
  • Gaziano TA. Cardiovascular disease in the developing world and its cost-effective management. Circulation. 2005 Dec 6;112(23):3547–3553.
  • Fuster V, Voute J, Hunn M, et al. Low priority of cardiovascular and chronic diseases on the global health agenda: a cause for concern. Circulation. 2007 Oct 23;116(17):1966–1970.
  • Ford ES, Ajani UA, Croft JB, et al. Explaining the decrease in U.S. deaths from coronary disease, 1980–2000. N Engl J Med. 2007 Jun 7;356(23):2388–2398.
  • Gu K, Cowie CC, Harris MI. Diabetes and decline in heart disease mortality in US adults. JAMA. 1999 Apr 14;281(14):1291–1297.
  • Expert Panel on Detection E, Treatment of High Blood Cholesterol in A. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA. 2001 May 16;285(19):2486–2497.
  • Fox CS, Coady S, Sorlie PD, et al. Trends in cardiovascular complications of diabetes. JAMA. 2004 Nov 24;292(20):2495–2499.
  • Preis SR, Hwang SJ, Coady S, et al. Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham heart study, 1950 to 2005. Circulation. 2009 Apr 7;119(13):1728–1735.
  • Centers for Disease C, Prevention. Trends in ischemic heart disease death rates for blacks and whites–United States, 1981–1995. MMWR Morb Mortal Wkly Rep. 1998 Nov 13;47(44):945–949.
  • Howard G, Howard VJ, Geographic R, et al. Ethnic disparities in stroke: the scope of the problem. Ethn Dis. 2001 Fall;11(4):761–768.
  • Gaines K, Burke G. Ethnic differences in stroke: black-white differences in the United States population. SECORDS investigators. Southeastern consortium on racial differences in stroke. Neuroepidemiology. 1995;14(5):209–239.
  • Holmes JS, Arispe IE, Moy E. Heart disease and prevention: race and age differences in heart disease prevention, treatment, and mortality. Med Care. 2005 Mar;43(3 Suppl):I33–41.
  • Mensah GA, Mokdad AH, Ford ES, et al. State of disparities in cardiovascular health in the United States. Circulation. 2005 Mar 15;111(10):1233–1241.
  • Wong MD, Shapiro MF, Boscardin WJ, et al. Contribution of major diseases to disparities in mortality. N Engl J Med. 2002 Nov 14;347(20):1585–1592.
  • Bonow RO, Grant AO, Jacobs AK. The cardiovascular state of the union: confronting healthcare disparities. Circulation. 2005 Mar 15;111(10):1205–1207.
  • Yancy CW, Benjamin EJ, Fabunmi RP, et al. Discovering the full spectrum of cardiovascular disease: minority Health Summit 2003: executive summary. Circulation. 2005 Mar 15;111(10):1339–1349.
  • Veazie M, Ayala C, Schieb L, et al. Trends and disparities in heart disease mortality among American Indians/Alaska Natives, 1990–2009. Am J Public Health. 2014 Jun;104(Suppl 3):S359–67.
  • Centers for Disease C, Prevention. Disparities in premature deaths from heart disease–50 states and the district of Columbia, 2001. MMWR Morb Mortal Wkly Rep. 2004 Feb 20;53(6):121–125.
  • Rw N. Diabetes and heart disease. In: Braunwald ELP, Bonow RO, Zipes DP, Mann DL, editors. Braunwald’s Heart Disease: a textbook of cardiovascular medicine. Vol. 1. 8th ed. Philadelphia: Saunders Elsevier; 2008. p. 1547–1560.
  • Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA. 1979 May 11;241(19):2035–2038.
  • Saaddine JB, Engelgau MM, Beckles GL, et al. A diabetes report card for the United States: quality of care in the 1990s. Ann Intern Med. 2002 Apr 16;136(8):565–574.
  • Kirk JK, Bell RA, Bertoni AG, et al. A qualitative review of studies of diabetes preventive care among minority patients in the United States, 1993–2003. Am J Manag Care. 2005 Jun;11(6):349–360.
  • Moreno PR, Murcia AM, Palacios IF, et al. Coronary composition and macrophage infiltration in atherectomy specimens from patients with diabetes mellitus. Circulation. 2000 Oct 31;102(18):2180–2184.
  • Pilote L, Dasgupta K, Guru V, et al. A comprehensive view of sex-specific issues related to cardiovascular disease. Cmaj. 2007 Mar 13;176(6):S1–44.
  • Kautzky-Willer A, Handisurya A. Metabolic diseases and associated complications: sex and gender matter! Eur J Clin Invest. 2009 Aug;39(8):631–648.
  • Lundberg V, Stegmayr B, Asplund K, et al. Diabetes as a risk factor for myocardial infarction: population and gender perspectives. J Intern Med. 1997 Jun;241(6):485–492.
  • Natarajan S, Liao Y, Cao G, et al. Sex differences in risk for coronary heart disease mortality associated with diabetes and established coronary heart disease. Arch Internal Med. 2003 Jul 28;163(14):1735–1740.
  • Natarajan S, Liao Y, Sinha D, et al. Sex differences in the effect of diabetes duration on coronary heart disease mortality. Arch Internal Med. 2005 Feb 28;165(4):430–435.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.